These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Efficient generation of constrained block allocation sequences. Salama I; Ivanova A; Qaqish B Stat Med; 2008 Apr; 27(9):1421-8. PubMed ID: 17729381 [TBL] [Abstract][Full Text] [Related]
29. Case-only analysis of treatment-covariate interactions in clinical trials. Vittinghoff E; Bauer DC Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319 [TBL] [Abstract][Full Text] [Related]
30. New algorithm for treatment allocation reduced selection bias and loss of power in small trials. Hofmeijer J; Anema PC; van der Tweel I J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784 [TBL] [Abstract][Full Text] [Related]
31. Multiple population models for multivariate random length data--with applications in clinical trials. Barnhart HX; Sampson AR Biometrics; 1995 Mar; 51(1):195-204. PubMed ID: 7766774 [TBL] [Abstract][Full Text] [Related]
32. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected. Kafadar K; Prorok PC Stat Med; 2009 Jul; 28(16):2116-46. PubMed ID: 19424959 [TBL] [Abstract][Full Text] [Related]
33. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups. Kawaguchi A; Koch GG; Ramaswamy R Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698 [TBL] [Abstract][Full Text] [Related]
34. A comparison of the randomized play-the-winner rule and the triangular test for clinical trials with binary responses. Coad DS; Rosenberger WF Stat Med; 1999 Apr; 18(7):761-9. PubMed ID: 10327525 [TBL] [Abstract][Full Text] [Related]
36. Comment on: on the design and analysis of randomized clinical trials with multiple endpoints. Lehmacher W; Wassmer G; Reitmeir P Biometrics; 1994 Jun; 50(2):581-3. PubMed ID: 8068855 [No Abstract] [Full Text] [Related]
37. Brick tunnel randomization for unequal allocation to two or more treatment groups. Kuznetsova OM; Tymofyeyev Y Stat Med; 2011 Apr; 30(8):812-24. PubMed ID: 21432876 [TBL] [Abstract][Full Text] [Related]
38. Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs. Piccorelli AV; Fraker SA J Biopharm Stat; 2018; 28(6):1105-1118. PubMed ID: 29442610 [TBL] [Abstract][Full Text] [Related]
39. Non-parametric bounds on treatment effects with non-compliance by covariate adjustment. Cai Z; Kuroki M; Sato T Stat Med; 2007 Jul; 26(16):3188-204. PubMed ID: 17136775 [TBL] [Abstract][Full Text] [Related]
40. A random walk rule for phase I clinical trials. Durham SD; Flournoy N; Rosenberger WF Biometrics; 1997 Jun; 53(2):745-60. PubMed ID: 9192462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]